{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["CD86", "DRB1*15", "Pediatric onset", "gene\u2013environment interaction", "multiple sclerosis", "ozone pollution"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "35000467", "DateCompleted": {"Year": "2022", "Month": "07", "Day": "06"}, "DateRevised": {"Year": "2022", "Month": "08", "Day": "02"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2022", "Month": "01", "Day": "08"}], "ELocationID": ["10.1177/13524585211069926"], "Journal": {"ISSN": "1477-0970", "JournalIssue": {"Volume": "28", "Issue": "9", "PubDate": {"Year": "2022", "Month": "Aug"}}, "Title": "Multiple sclerosis (Houndmills, Basingstoke, England)", "ISOAbbreviation": "Mult Scler"}, "ArticleTitle": "Gene-environment interactions increase the risk of pediatric-onset multiple sclerosis associated with ozone pollution.", "Pagination": {"StartPage": "1330", "EndPage": "1339", "MedlinePgn": "1330-1339"}, "Abstract": {"AbstractText": ["We previously reported a relationship between air pollutants and increased risk of pediatric-onset multiple sclerosis (POMS). Ozone is an air pollutant that may play a role in multiple sclerosis (MS) pathoetiology. <i>CD86</i> is the only non-HLA gene associated with POMS for which expression on antigen-presenting cells (APCs) is changed in response to ozone exposure.", "To examine the association between county-level ozone and POMS, and the interactions between ozone pollution, <i>CD86</i>, and <i>HLA</i>-<i>DRB1*15</i>, the strongest genetic variant associated with POMS.", "Cases and controls were enrolled in the Environmental and Genetic Risk Factors for Pediatric MS study of the US Network of Pediatric MS Centers. County-level-modeled ozone data were acquired from the CDC's Environmental Tracking Network. Participants were assigned ozone values based on county of residence. Values were categorized into tertiles based on healthy controls. The association between ozone tertiles and having MS was assessed by logistic regression. Interactions between tertiles of ozone level and the GG genotype of the rs928264 (G/A) single nucleotide polymorphism (SNP) within <i>CD86</i>, and the presence of <i>DRB1*15:01</i> (<i>DRB1*15</i>) on odds of POMS were evaluated. Models were adjusted for age, sex, genetic ancestry, and mother's education. Additive interaction was estimated using relative excess risk due to interaction (RERI) and attributable proportions (APs) of disease were calculated.", "A total of 334 POMS cases and 565 controls contributed to the analyses. County-level ozone was associated with increased odds of POMS (odds ratio 2.47, 95% confidence interval (CI): 1.69-3.59 and 1.95, 95% CI: 1.32-2.88 for the upper two tertiles, respectively, compared with the lowest tertile). There was a significant additive interaction between high ozone tertiles and presence of <i>DRB1*15</i>, with a RERI of 2.21 (95% CI: 0.83-3.59) and an AP of 0.56 (95% CI: 0.33-0.79). Additive interaction between high ozone tertiles and the <i>CD86</i> GG genotype was present, with a RERI of 1.60 (95% CI: 0.14-3.06) and an AP of 0.37 (95% CI: 0.001-0.75) compared to the lowest ozone tertile. AP results indicated that approximately half of the POMS risk in subjects can be attributed to the possible interaction between higher county-level ozone carrying either <i>DRB1*15</i> or the <i>CD86</i> GG genotype.", "In addition to the association between high county-level ozone and POMS, we report evidence for additive interactions between higher county-level ozone and <i>DRB1*15</i> and the <i>CD86</i> GG genotype. Identifying gene-environment interactions may provide mechanistic insight of biological processes at play in MS susceptibility. Our work suggests a possible role of APCs for county-level ozone-induced POMS risk."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of California, San Francisco, San Francisco, CA, USA."}], "LastName": "Ziaei", "ForeName": "Amin", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Child Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, USA."}], "LastName": "Lavery", "ForeName": "Amy M", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Genetic Epidemiology and Genomics Laboratory, Divisions of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley, Berkeley, CA, USA."}], "LastName": "Shao", "ForeName": "Xiaorong Ma", "Initials": "XM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Genetic Epidemiology and Genomics Laboratory, Divisions of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley, Berkeley, CA, USA."}], "LastName": "Adams", "ForeName": "Cameron", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The University of Utah, Salt Lake City, UT, USA."}], "LastName": "Casper", "ForeName": "T Charles", "Initials": "TC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The University of Utah, Salt Lake City, UT, USA."}], "LastName": "Rose", "ForeName": "John", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The University of Utah, Salt Lake City, UT, USA."}], "LastName": "Candee", "ForeName": "Meghan", "Initials": "M"}, {"Identifier": ["0000-0001-6732-151X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Buffalo General Hospital, State University of New York at Buffalo, Buffalo, NY, USA."}], "LastName": "Weinstock-Guttman", "ForeName": "Bianca", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Loma Linda University Children's Hospital, Loma Linda, CA, USA."}], "LastName": "Aaen", "ForeName": "Greg", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The University of Alabama, Tuscaloosa, AL, USA."}], "LastName": "Harris", "ForeName": "Yolanda", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of California, San Diego, San Diego, CA, USA."}], "LastName": "Graves", "ForeName": "Jennifer", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pediatric Multiple Sclerosis and Related Disorders Program, Boston Children's Hospital, Boston, MA, USA."}], "LastName": "Benson", "ForeName": "Leslie", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pediatric Multiple Sclerosis and Related Disorders Program, Boston Children's Hospital, Boston, MA, USA."}], "LastName": "Gorman", "ForeName": "Mark", "Initials": "M"}, {"Identifier": ["0000-0001-9613-8394"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cleveland Clinic, Cleveland, OH, USA."}], "LastName": "Rensel", "ForeName": "Mary", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Washington University in St. Louis, St. Louis, MO, USA."}], "LastName": "Mar", "ForeName": "Soe", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Texas Children's Hospital, Houston, TX, USA."}], "LastName": "Lotze", "ForeName": "Tim", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Texas Southwestern Medical Center, Dallas, TX, USA."}], "LastName": "Greenberg", "ForeName": "Benjamin", "Initials": "B"}, {"Identifier": ["0000-0002-9897-4422"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA."}], "LastName": "Chitnis", "ForeName": "Tanuja", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of California, San Francisco, San Francisco, CA, USA."}], "LastName": "Hart", "ForeName": "Janace", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Child Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, USA."}], "LastName": "Waldman", "ForeName": "Amy T", "Initials": "AT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Genetic Epidemiology and Genomics Laboratory, Divisions of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley, Berkeley, CA, USA."}], "LastName": "Barcellos", "ForeName": "Lisa F", "Initials": "LF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of California, San Francisco, San Francisco, CA, USA."}], "LastName": "Waubant", "ForeName": "Emmanuelle", "Initials": "E"}], "GrantList": [{"GrantID": "R01 NS071463", "Acronym": "NS", "Agency": "NINDS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, N.I.H., Extramural"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Mult Scler", "NlmUniqueID": "9509185", "ISSNLinking": "1352-4585"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "B7-2 Antigen"}, {"RegistryNumber": "0", "NameOfSubstance": "CD86 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "HLA-DRB1 Chains"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": ["genetics"], "DescriptorName": "B7-2 Antigen"}, {"QualifierName": [], "DescriptorName": "Child"}, {"QualifierName": [], "DescriptorName": "Gene-Environment Interaction"}, {"QualifierName": [], "DescriptorName": "Genetic Predisposition to Disease"}, {"QualifierName": [], "DescriptorName": "Genotype"}, {"QualifierName": ["genetics"], "DescriptorName": "HLA-DRB1 Chains"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["genetics"], "DescriptorName": "Multiple Sclerosis"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Risk Factors"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Waubant E, Lucas R, Mowry E, Graves J, Olsson T, Alfredsson L, et al. Environmental and genetic risk factors for MS: an integrated review. Annals of Clinical and Translational Neurology. 2019;6(9):1905\u201322.", "ArticleIdList": ["PMC6764632", "31392849"]}, {"Citation": "Lavery AM, Waldman AT, Charles Casper T, Roalstad S, Candee M, Rose J, et al.\nExamining the contributions of environmental quality to pediatric multiple sclerosis. Multiple Sclerosis and Related Disorders [Internet]. 2017. \nNov\n1 [cited 2020 Apr 22];18:164\u20139. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29141802", "ArticleIdList": ["PMC5720353", "29141802"]}, {"Citation": "Lavery AM, Waubant E, Casper TC, Roalstad S, Candee M, Rose J, et al. Urban air quality and associations with pediatric multiple sclerosis. Annals of Clinical and Translational Neurology. 2018;5(10):1146\u201353.", "ArticleIdList": ["PMC6186930", "30349849"]}, {"Citation": "Zhang JJ, Wei Y, Fang Z. Ozone pollution: A major health hazard worldwide. Frontiers in Immunology. 2019;10(OCT):1\u201310.", "ArticleIdList": ["PMC6834528", "31736954"]}, {"Citation": "Jakab GJ, Spannhake Wm. E, Canning BJ, Kleeberger SR, Gilmour MI. The effects of ozone on immune function. Environmental Health Perspectives. 1995;103(SUPPL. 2):77\u201389.", "ArticleIdList": ["PMC1518840", "7614952"]}, {"Citation": "Ozbay I, Ital I, Kucur C, Akcilar R, Deger A, Aktas S, et al. Efeitos da terapia com oz\u00f4nio na regenera\u00e7\u00e3o do nervo facial. Brazilian Journal of Otorhinolaryngology. 2017;83(2):168\u201375.", "ArticleIdList": ["PMC9442687", "27174776"]}, {"Citation": "Esmaeil Mousavi S, Heydarpour P, Reis J, Amiri M, Sahraian MA. Multiple sclerosis and air pollution exposure: Mechanisms toward brain autoimmunity. Medical Hypotheses. 2017;100(2):23\u201330.", "ArticleIdList": ["28236843"]}, {"Citation": "Mumaw CL, Levesque S, McGraw C, Robertson S, Lucas S, Stafflinger JE, et al. Microglial priming through the lung-brain axis: The role of air pollution-induced circulating factors. FASEB Journal. 2016. May 1;30(5):1880\u201391.", "ArticleIdList": ["PMC4836369", "26864854"]}, {"Citation": "Bai L, Burnett RT, Kwong JC, Hystad P, van Donkelaar A, Brook JR, et al. Long-term exposure to air pollution and the incidence of multiple sclerosis: A population-based cohort study. Environmental Research. 2018;166(June):437\u201343.", "ArticleIdList": ["29940476"]}, {"Citation": "Zhao N, Pinault L, Toyib O, Vanos J, Tjepkema M, Cakmak S. Long-term ozone exposure and mortality from neurological diseases in Canada. Environment International. 2021. Dec 1;157:106817.", "ArticleIdList": ["34385046"]}, {"Citation": "Gianfrancesco MA, Stridh P, Shao X, Rhead B, Graves JS, Chitnis T, et al. Genetic risk factors for pediatric-onset multiple sclerosis. Multiple Sclerosis Journal. 2018. Dec 1;24(14):1825\u201334.", "ArticleIdList": ["PMC5878964", "28980494"]}, {"Citation": "Hollingsworth JW, Free ME, Li Z, Andrews LN, Nakano H, Cook DN. Ozone activates pulmonary dendritic cells and promotes allergic sensitization through a Toll-like receptor 4-dependent mechanism. Journal of Allergy and Clinical Immunology. 2010;125(5):1167\u201370.", "ArticleIdList": ["PMC2866779", "20394980"]}, {"Citation": "Daily Census Tract-Level Ozone Concentrations, 2011\u20132014 | Data | Centers for Disease Control and Prevention;  [Internet]. [cited 2020 May 30]. Available from: https://data.cdc.gov/Environmental-Health-Toxicology/Daily-Census-Tract-Level-Ozone-Concentrations-2011/372p-dx3h"}, {"Citation": "Cortes A, Pulit SL, Leo PJ, Pointon JJ, Robinson PC, Weisman MH, et al. Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1. Nature Communications. 2015;6(May).", "ArticleIdList": ["PMC4443427", "25994336"]}, {"Citation": "Smets I, Fiddes B, Garcia-Perez JE, He D, Mallants K, Liao W, et al. Multiple sclerosis risk variants alter expression of co-stimulatory genes in B cells. Brain. 2018;141(3):786\u201396.", "ArticleIdList": ["PMC5837558", "29361022"]}, {"Citation": "Nourbakhsh B, Rutatangwa A, Waltz M, Rensel M, Moodley M, Graves J, et al. Heterogeneity in association of remote herpesvirus infections and pediatric MS. Annals of Clinical and Translational Neurology. 2018. Oct 1;5(10):1222\u20138.", "ArticleIdList": ["PMC6186938", "30349857"]}, {"Citation": "Chen CY, Pollack S, Hunter DJ, Hirschhorn JN, Kraft P, Price AL. Improved ancestry inference using weights from external reference panels. Bioinformatics. 2013. Jun 1;29(11):1399\u2013406.", "ArticleIdList": ["PMC3661048", "23539302"]}, {"Citation": "Lavery AM, Collins BN, Waldman AT, Hart CN, Bar-Or A, Marrie RA, et al.\nThe contribution of secondhand tobacco smoke exposure to pediatric multiple sclerosis risk. Multiple Sclerosis Journal [Internet]. 2019. \nApr\n1 [cited 2020 Aug 15];25(4):515\u201322. Available from: https://pubmed.ncbi.nlm.nih.gov/29393768/", "ArticleIdList": ["29393768"]}, {"Citation": "Vanderweele TJ, Knol MJ. A Tutorial on Interaction. Epidemiol Methods. 2014;3(1):33\u201372."}, {"Citation": "Muller CJ, Maclehose RF. Estimating predicted probabilities from logistic regression: Different methods correspond to different target populations. International Journal of Epidemiology. 2014;43(3):962\u201370.", "ArticleIdList": ["PMC4052139", "24603316"]}, {"Citation": "Puhan MA, Chandra D, Mosenifar Z, Ries A, Make B, Hansel NN, et al. Ozone, NO2 and PM10 are associated with the occurrence of multiple sclerosis relapses. 2017;37(4):784\u201390.", "ArticleIdList": ["PMC5516638", "20693247"]}, {"Citation": "Patsopoulos NA, Barcellos LF, Hintzen RQ, Schaefer C, van Duijn CM, Noble JA, et al. Fine-Mapping the Genetic Association of the Major Histocompatibility Complex in Multiple Sclerosis: HLA and Non-HLA Effects. PLoS Genetics. 2013. Nov 1;9(11).", "ArticleIdList": ["PMC3836799", "24278027"]}, {"Citation": "Poorolajal J, Bahrami M, Karami M, Hooshmand E. Effect of smoking on multiple sclerosis: A meta-analysis. Journal of Public Health (United Kingdom). 2017. Jun 1;39(2):312\u201320.", "ArticleIdList": ["27160862"]}, {"Citation": "Barrag\u00e1n-Mart\u00ednez C, Speck-Hern\u00e1ndez CA, Montoya-Ortiz G, Mantilla RD, Anaya JM, Rojas-Villarraga A, et al. Organic Solvents as Risk Factor for Autoimmune Diseases: A Systematic Review and Meta-Analysis. PLoS ONE. 2012. Dec 19;7(12):e51506.", "ArticleIdList": ["PMC3526640", "23284705"]}, {"Citation": "Azuma M, Ito D, Yagita H, Okumura K, Phillips JH, Lanier LL, et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature. 1993;366(6450):76\u20139.", "ArticleIdList": ["7694153"]}, {"Citation": "Kuchroo VK, Prabhu Das M, Brown JA, Ranger AM, Zamvil SS, Sobel RA, et al. B7\u20131 and B7\u20132 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell. 1995. Mar 10;80(5):707\u201318.", "ArticleIdList": ["7534215"]}, {"Citation": "Niino M, Hirotani M, Miyazaki Y, Sasaki H. Memory and na\u00efve B-cell subsets in patients with multiple sclerosis. Neuroscience Letters. 2009. Oct 16;464(1):74\u20138.", "ArticleIdList": ["19666086"]}, {"Citation": "Fraussen J, Claes N, Van Wijmeersch B, van Horssen J, Stinissen P, Hupperts R, et al. B cells of multiple sclerosis patients induce autoreactive proinflammatory T cell responses. Clinical Immunology. 2016. Dec 1;173:124\u201332.", "ArticleIdList": ["27717695"]}, {"Citation": "Filion LG, Matusevicius D, Graziani-Bowering GM, Kumar A, Freedman MS. Monocyte-derived IL12, CD86 (B7\u20132) and CD40L expression in relapsing and progressive multiple sclerosis. Clinical Immunology. 2003. Feb 1;106(2):127\u201338.", "ArticleIdList": ["12672403"]}, {"Citation": "Zeinstra E, Wilczak N, De Keyser J. Reactive astrocytes in chronic active lesions of multiple sclerosis express co-stimulatory molecules B7\u20131 and B7\u20132. Journal of Neuroimmunology. 2003;135(1\u20132):166\u201371.", "ArticleIdList": ["12576238"]}, {"Citation": "Sawcer S, Hellenthal G, Pirinen M, Spencer CCA, Patsopoulos NA, Moutsianas L, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Vol. 476, Nature. Europe PMC Funders; 2011. p. 214\u20139.", "ArticleIdList": ["PMC3182531", "21833088"]}, {"Citation": "R\u00fchl G, Niedl AG, Patronov A, Siewert K, Pinkert S, Kalemanov M, et al. Multiple sclerosis: Molecular mimicry of an antimyelin HLA class I restricted T-cell receptor. Neurology: Neuroimmunology and NeuroInflammation. 2016;3(4).", "ArticleIdList": ["PMC4871805", "27231714"]}, {"Citation": "Friese MA, Jakobsen KB, Friis L, Etzensperger R, Craner MJ, McMahon RM, et al. Opposing effects of HLA class I molecules in tuning autoreactive CD8 + T cells in multiple sclerosis. Nature Medicine. 2008. Nov;14(11):1227\u201335.", "ArticleIdList": ["18953350"]}, {"Citation": "Rothman KJ, Greenland S, Walker AM. Concepts of interaction. American Journal of Epidemiology. 1980;112(4):467\u201370.", "ArticleIdList": ["7424895"]}, {"Citation": "Abdul Shakor AS ad, Pahrol MA, Mazeli MI. Effects of Population Weighting on PM10 Concentration Estimation. Journal of Environmental and Public Health. 2020;2020.", "ArticleIdList": ["PMC7174967", "32351580"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "1", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "1", "Day": "10", "Hour": "5", "Minute": "34"}, {"Year": "2022", "Month": "8", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35000467", "NIHMS1764211", "PMC9256753", "10.1177/13524585211069926"]}}], "PubmedBookArticle": []}